A

Applied Therapeutics
D

APLT

0.53390
USD
-0.03
(-5.22%)
مغلق
حجم التداول
40,406
الربح لكل سهم
-0
العائد الربحي
-
P/E
-0
حجم السوق
62,122,721
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
الأخبار
المقالات

العنوان: Applied Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.